pioglitazone has been researched along with Hepato-Pulmonary Syndrome in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, HC | 1 |
| Yang, YY | 1 |
| Cheng, TY | 1 |
| Lee, WS | 1 |
| Huang, HC | 1 |
| Lee, FY | 1 |
| Chang, CC | 1 |
| Lin, HC | 1 |
| Lee, SD | 1 |
2 other studies available for pioglitazone and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Pioglitazone decrease intrapulmonary shunt in biliary cirrhotic rats with hepatopulmonary syndrome.
Topics: Animals; Hepatopulmonary Syndrome; Liver Cirrhosis; Pioglitazone; Rats; Thiazolidinediones | 2017 |
The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
Topics: Angiogenesis Inhibitors; Animals; Endothelin-1; Hepatopulmonary Syndrome; Liver Cirrhosis; Male; Nit | 2017 |